Table 2.
Patient demographic and diagnostic information: 60-year-old female presented with unstable angina on a background of ischaemic heart disease, dyslipidaemia, raised body mass index, asthma/chronic airways obstruction and hiatus hernia. | ||||
---|---|---|---|---|
Pre-admission medication list | Changes made | Final inpatient prescription and administration chart | Discharge prescription | Discharge summary |
Elantan LA [Isosorbide mononitrate long acting (LA)] 25 od | Discontinued | \\ | Nil mentioned | Nil mentioned |
Becotide 250 inh (Beclometasone inhaler) 2 puffs bd | 0 | Becotide 250 inh 2 puffs bd | Becotide 250 inh 2 puffs bd | Becotide 250 inh 2 puffs bd |
Spiriva (Tiotropium) 18 mcg 1 puff od | 0 | Spiriva 18 mcg 1 puff od | Spiriva 18 mcg 1 puff od | Spiriva 18 mcg 1 puff od |
Omeprazole 20 mg od | Increased to 40 mg od | Omeprazole 40 mg od | Omeprazole 40 mg od | Omeprazole 40 mg od |
Atenolol 25 mg od | 0 | Atenolol 25 mg od | Atenolol 25 mg od | Atenolol 25 mg od |
Detrusitol (Tolterodine) 1 mg bd | 0 | Detrusitol 1 mg bd | Detrusitol | Detrusitol 1 mg bd |
Aspirin 75 mg od | 0 | Aspirin 75 mg od | Aspirin 75 mg od | Aspirin 75 mg od |
Omacor (Omega III) 1 caps od | 0 | Omacor 1 caps od | Omacor 1 caps od | Omacor 1 caps od |
Flurazepam 30 mg no | 0 | Flurazepam 30 mg no | Omitted | Omitted |
Diazepam 5 mg tds | 0 | Diazepam 5 mg tds | Diazepam | Diazepam 5 mg bd |
Pravastatin 20 mg no | 0 | Pravastatin 20 mg no | Pravastatin 20 mg no | Pravastatin 20 mg no |
Potential for patient harm | Minor | |||
Potential for unplanned re-admission within 3 months | Low |
Patient demographic and diagnostic information: 75-year-old male presented with ischaemic heart disease on a background of atrial fibrillation, diabetes and congestive cardiac failure. | ||||
---|---|---|---|---|
Pre-admission medication list | Changes made | Final inpatient prescription and administration chart | Discharge prescription | Discharge summary |
Clopidogrel 75 mg od | 0 | Clopidogrel 75 mg od | Clopidogrel 75 mg od | Clopidogrel 75 mg od |
Protium (Pantoprazole) 40 mg od | 0 | Protium 40 mg od | Protium 40 mg od | Omitted |
Atorvastatin 40 mg od | 0 | Atorvastatin 40 mg od | Atorvastatin 40 mg od | Atorvastatin 40 mg od |
Amlodipine 10 mg od | 0 | Amlodipine 10 mg od | Amlodipine 10 mg od | Amlodipine 10 mg od |
Aspirin 75 mg od | 0 | Aspirin 75 mg od | Aspirin 75 mg od | Aspirin 75 mg od |
Bisoprolol 5 mg od | 0 | Bisoprolol 5 mg od | Bisoprolol 5 mg od | Bisoprolol 5 mg od |
Warfarin | Held | ‘Hold’ | Nil mentioned | ‘Wa’ |
Burinex (Bumetanide) 1 mg od | Changed to furosemide | Furosemide 40 mg od | Furosemide 40 mg od | Furosemide 40 mg od |
Perindopril 4 mg od | 0 | Perindopril 4 mg od | Perindopril 4 mg od | Perindopril 4 mg od |
Insulin Novorapid (Aspart) 18 units tds | 0 | Insulin Novorapid 18 units tds | Insulin Novorapid 18 units tds | Insulin Novorapid 18 units tds |
Spironolactone 25 mg od | 0 | Spironolactone 25 mg od | Spironolactone 25 mg od | Spironolactone 25 mg od |
+ Iron 1 bd | Iron 1 bd | Iron 1 bd | Iron 1 bd | |
Potential for patient harm | Moderate | |||
Potential for unplanned re-admission within 3 months | Medium |
Patient demographic and diagnostic information: 89-year-old female presented with malaena, diagnosed with gastric carcinoma and liver metastases on a background of aortic stenosis, mitral regurgitation, hypothyroidism and atrial fibrillation. | ||||
---|---|---|---|---|
Pre-admission medication list | Changes made | Final inpatient prescription and administration chart | Discharge prescription | Discharge summary |
Pravastatin 40 mg od | 0 | Pravastatin 10 mg od | Pravastatin 10 mg od | Pravastatin 10 mg od |
Warfarin | Discontinued by consultant geriatrician | \\ | \\ | Warfarin |
Bisoprolol 2.5 mg od | Bisoprolol 2.5 mg od | Bisoprolol 2.5 mg od | Bisoprolol 2.5 mg od | |
Eltroxin (Levothyroxine) 50 mcg od | Eltroxin 50 mcg od | Eltroxin 50 mcg od | Eltroxin 50 mcg od | |
+ Losec (Omeprazole) | Losec 40 mg od | Losec 40 mg od | Omitted | |
‘Consider bone protection on discharge’ | Nil | Nil | Nil mentioned | |
+ Digoxin | Digoxin 62.5 mcg od | Digoxin 125mcg od | Omitted | |
Potential for patient harm | Severe | |||
Potential for unplanned re-admission within 3 months | High |
This table presents verbatim the entries made in the patient's healthcare record. Details in italics represent information added by the authors for explanatory purpose. The bold font indicates where non-reconciliations were identified. Bd, twice daily; mcg, microgram; mg, milligram; nocte, at night; od, once daily; tds, three times daily.